« Previous
Next »
Archives of Gerontology and Geriatrics
Volume 51, Issue 2
, Pages 149-151
, September 2010
Incidence of perioperative myocardial infarction and of 2-year mortality in 577 elderly patients undergoing noncardiac vascular surgery treated with and without statins
References
- . Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized and cohort study. J. Am. Med. Assoc. 2001;286:64–70
- . Treatment of high-risk older persons with lipid-lowering drug therapy. Am. J. Ther. 2008;15:102–107
- . Incidence of new coronary events in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol ≥125
mg/dl treated with statins versus no lipid-lowering drug. Am. J. Cardiol. 2002;89:67–69 - . Frequency of new coronary events in older persons with peripheral arterial disease and serum low-density lipoprotein cholesterol ≥125
mg/dl treated with statins versus no lipid-lowering drug. Am. J. Cardiol. 2002;90:789–791 - . Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J. Vasc. Surg. 2004;39:967–976
- . Association between long-term statin use and mortality after successful abdominal aortic aneurysm surgery. Am. J. Med. 2004;116:96–103
- . Inflammation and atherosclerosis. Circulation. 2002;105:1135–1143
- . Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation. 1997;95:1126–1131
- . Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery. The Statins for Risk Reduction in Surgery (StaRRS) Study. J. Am. Coll. Cardiol. 2005;45:336–342
- . Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation. 2003;107:1848–1851
- . Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. J. Am. Med. Assoc. 1998;279:1643–1650
- . Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler. Thromb. Vasc. Biol. 2001;21:1712–1719
- . Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation. Circulation. 2001;103:2248–2253
- . Anti-inflammatory and antithrombotic effects of statins in the management of coronary artery disease. Clin. Lab. 2002;48:287–296
PII: S0167-4943(09)00242-8
doi: 10.1016/j.archger.2009.09.042
© 2009 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
Archives of Gerontology and Geriatrics
Volume 51, Issue 2
, Pages 149-151
, September 2010
